In this article, we discuss 5 biotech stocks with biggest upside.
Keep Reading →
September 9 - News
Operator: Good morning and welcome to the Intellia Therapeutics' Second Quarter 2023 Earnings Conference Call. My name is Drew and I will be your conference operator today.
Keep Reading →
August 5 - News, Transcripts
In this article, we discuss 10 DNA stocks that billionaires love.
Keep Reading →
June 14 - Hedge Funds, News
Investing these days is a ride not for the faint hearted.
Keep Reading →
June 9 - Hedge Funds, News
Operator: Good morning and welcome to the Intellia Therapeutics' First Quarter 2023 Financial Results Conference Call.
Keep Reading →
May 5 - News, Transcripts
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
Keep Reading →
April 26 - Hedge Funds, News
In this article, we discuss 5 best mid-cap healthcare stocks to buy now.
Keep Reading →
April 25 - Hedge Funds, News
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) and its affiliated companies specialize in creating a platform for cell programming.
Keep Reading →
April 20 - Hedge Funds, News
In this article, we will take a look at the 5 most promising gene editing stocks according to analysts.
Keep Reading →
March 29 - Hedge Funds, News
The healthcare sector is one of the few industries that has rapidly transformed itself in just a couple of decades.
Keep Reading →
March 29 - News
Operator: Good morning and welcome to the Intellia Therapeutics' Fourth Quarter and Full Year 2022 Financial Results Conference Call.
Keep Reading →
March 1 - News, Transcripts
In this article, we discuss 5 most promising biotech stocks according to analysts.
Keep Reading →
February 25 - News
In this article, we discuss the 15 biggest positions in the ARK Invest portfolio.
Keep Reading →
February 14 - Hedge Funds, News
If there's one thing that can be said for certain in today's highly volatile environment, it's that 2022 has not been a good year for Cathie Wood. Ms.
Keep Reading →
December 24 - Hedge Funds, News
In this article, we discuss the 14 best ARK stocks to buy now.
Keep Reading →
December 16 - Hedge Funds, News
In this article, we discuss 10 best biotech stocks to buy according to hedge funds.
Keep Reading →
November 25 - Hedge Funds, News
In this piece, we will take a look at the five most promising gene therapy companies to watch.
Keep Reading →
November 14 - News
In this article, we will discuss the 5 Biggest Genomics Companies In The World.
Keep Reading →
October 28 - News
In this article, we discuss the top 10 stock picks from the ARK Invest stock portfolio.
Keep Reading →
October 19 - Hedge Funds, News
Graphite Bio, Inc. (NASDAQ:GRPH) is a clinical-stage gene editing company based in San Francisco, California.
Keep Reading →
October 14 - Hedge Funds, News
In this article, we discuss 10 stocks that Cathie Wood is buying in September.
Keep Reading →
September 19 - Hedge Funds, News
In this article, we will be taking a look at the top 12 from Cathie Wood's Q2 portfolio.
Keep Reading →
August 29 - Hedge Funds, News
In this article, we discuss the 3 stocks that Cathie Wood dumped in July.
Keep Reading →
July 29 - Hedge Funds, News
In this article, we discuss 5 stocks that Cathie Wood is not letting go of despite losses.
Keep Reading →
July 25 - Hedge Funds, News
In this article, we discuss 10 stocks to watch as Cathie Wood's fund starts to rebound.
Keep Reading →
July 14 - Hedge Funds, News
In this article, we discuss the 12 best ARK stocks to buy now.
Keep Reading →
May 30 - Hedge Funds, News
Tesla, Inc. (NASDAQ:TSLA), the American EV giant, is down over 37% year-to-date as of May 27.
Keep Reading →
May 30 - Hedge Funds, News
In this article, we discuss the 10 biggest losers in Cathie Wood's latest portfolio.
Keep Reading →
May 17 - Hedge Funds, News
In this article, we discuss Cathie Wood's 10 stock picks for the next 5 years.
Keep Reading →
March 21 - Hedge Funds, News
In this article, we discuss 5 genomics stocks in Cathie Wood’s portfolio that are underperforming.
Keep Reading →
February 23 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file ...
Keep Reading →
February 5 - Hedge Funds, News
In this article, we will discuss the 5 best genomics stocks to buy now.
Keep Reading →
December 17 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
December 8 - Hedge Funds, News
In this article article, we reviewed Jay Chen’s investment philosophy and portfolio management strategies.
Keep Reading →
October 28 - News
In this article, we will take a look at the 5 best genomic stocks to buy now.
Keep Reading →
October 19 - Hedge Funds, News
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money ...
Keep Reading →
October 12 - Hedge Funds, News
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” second quarter 2021 investor letter – a copy of which can be...
Keep Reading →
September 17 - Hedge Fund Investor Letters, News
As technology and growth stocks surged during the pandemic, ARK Investment Management and Cathie Wood became two of retail investors' favorites over the previous year.
Keep Reading →
August 26 - Hedge Funds, News
Is Intellia Therapeutics, Inc.
Keep Reading →
July 6 - Hedge Funds, News
In this article we discuss the 10 best pharmaceutical stocks to buy according to Cathie Wood.
Keep Reading →
June 2 - Hedge Funds, News
In this article we discuss the 5 best biotech stocks to buy according to Cathie Wood.
Keep Reading →
May 25 - Hedge Funds, News
In this article we will take a look at the 10 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
Keep Reading →
May 12 - Hedge Funds, News
In this article you are going to find out whether hedge funds think Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a good investment right now.
Keep Reading →
April 14 - Hedge Funds, News
In this article we talk about 15 fastest growing biotech companies in the US.
Keep Reading →
February 27 - Lists, News
Intellia Therapeutics Inc.
Keep Reading →
January 9 - News, Stock Analysis
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Keep Reading →
December 16 - Hedge Funds, News
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Keep Reading →
October 30 - Hedge Funds, News
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and ...
Keep Reading →
June 29 - Hedge Funds, News
Please follow OrbiMed Advisors (if you aren't already doing so) to get real-time email alerts whenever we publish an article about OrbiMed Advisors or update its stock holdings...
Keep Reading →
November 9 - Hedge Funds
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Keep Reading →
December 12 - Hedge Funds, News